U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
9591195911Immune Response Study of Influenza VaccineCompletedNo Results AvailableInfluenza Vaccine Allergy|Cell Mediated Reactionhttps://ClinicalTrials.gov/show/NCT01310374
9591295912Once-daily Therapy for Streptococcal PharyngitisCompletedNo Results AvailableStreptococcal Sore ThroatDrug: Amoxicillin|Drug: Intramuscular Benzathin Penicillin Ghttps://ClinicalTrials.gov/show/NCT01310361
9591395913Effect of Bone on Vibration-Induced Muscle Strength GainCompletedNo Results AvailableBone Mass|Effects of VibrationDevice: whole-body vibration (WBV)|Device: WBV (Sham stimulation)https://ClinicalTrials.gov/show/NCT01310348
9591495914Effect of Whole-Body Vibration on Plasma Sclerostin LevelCompletedNo Results AvailableBone Mass|Effects of VibrationDevice: whole-body vibration (WBV)https://ClinicalTrials.gov/show/NCT01310335
9591595915A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different WaysCompletedNo Results AvailableHealthy|AsthmaDrug: AZD5423|Drug: AZD5423|Drug: AZD5423|Drug: AZD5423https://ClinicalTrials.gov/show/NCT01310322
9591695916EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel DiseaseCompletedNo Results AvailableCoronary Disease|Coronary Artery Disease|Coronary Artery Stenosis|Coronary Artery RestenosisDevice: Coronary artery placement of a drug-eluting stenthttps://ClinicalTrials.gov/show/NCT01310309
9591795917Lofexidine ADME & Mass Balance in VolunteersCompletedNo Results AvailableNormal Healthy Volunteers Will be Treated With Lofexidine to Understand the Absolute Bioavailbility and Mass Balance Recovery of the Product.Drug: Lofexidine hydrochloride|Drug: Lofexidine hydrochloridehttps://ClinicalTrials.gov/show/NCT01310296
9591895918Caries Management by Risk Assessment in ChildrenCompletedNo Results AvailableDental CariesOther: xylitol mints and fluoride varnishhttps://ClinicalTrials.gov/show/NCT01310283
9591995919The Effects of Omega-3 Fatty Acids Supplementation on Endothelial Function and InflammationCompletedNo Results AvailablePeripheral Arterial DiseaseDietary Supplement: Pro-Omega|Dietary Supplement: Omega 3 Fatty Acidhttps://ClinicalTrials.gov/show/NCT01310270
9592095920Measures of Pain Relevant to Knee OsteoarthritisCompletedNo Results AvailableOsteoarthritis of the KneeOther: Questionnaireshttps://ClinicalTrials.gov/show/NCT01310257
9592195921Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-Small-Cell Lung Cancer (NSCLC)CompletedNo Results AvailableStage IV Non-small Cell Lung CancerDrug: Belinostat, Carboplatin, Paclitaxelhttps://ClinicalTrials.gov/show/NCT01310244
9592295922A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Metformin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01310231
9592395923Length of Post Operative Dressing After Carpal Tunnel ReleaseCompletedNo Results AvailableCarpal Tunnel SyndromeOther: extended postoperative dressing|Other: short postoperative dressinghttps://ClinicalTrials.gov/show/NCT01310218
9592495924Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCVCompletedNo Results AvailableChronic Hepatitis CDrug: SCV-07https://ClinicalTrials.gov/show/NCT01310205
9592595925Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission TomographyCompletedNo Results AvailableProstate CancerDevice: Fluourine-18 Fluoromethylcholine PET/CT Imaginghttps://ClinicalTrials.gov/show/NCT01310192
9592695926Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid TumorsCompletedHas ResultsHead and Neck CancerGenetic: Ad/PNP and fludarabine monophosphatehttps://ClinicalTrials.gov/show/NCT01310179
9592795927Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisCompletedNo Results AvailableRelapsing-remitting Multiple SclerosisDrug: Fingolimodhttps://ClinicalTrials.gov/show/NCT01310166
9592895928Effect of Supine or Prone Position After Caesarean BirthCompletedNo Results AvailableRespiratory Distress|Transitory Tachypnea of Newborn|Delayed Transition of the Newborn|Persistent Pulmonary HypertensionProcedure: prone positioninghttps://ClinicalTrials.gov/show/NCT01310153
9592995929Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic FeaturesTerminatedNo Results AvailableMajor Depressive Disorder|Major Depressive Disorder w/ Psychotic Features|Metabolic Syndromehttps://ClinicalTrials.gov/show/NCT01310140
9593095930Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%CompletedHas ResultsInflammation|PseudophakiaDrug: Bromfenac|Drug: Nepafenachttps://ClinicalTrials.gov/show/NCT01310127
9593195931Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic StrokeTerminatedNo Results AvailableStroke, Acute|Middle Cerebral Artery Stroke|Posterior Cerebral Artery StrokeBiological: Human Placenta-Derived Cells PDA001- (cenplacel-L)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01310114
9593295932Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNo Results AvailableChronic Lymphocytic LeukemiaDrug: ofatumumab plus dexamethasonehttps://ClinicalTrials.gov/show/NCT01310101
9593395933Blood Pressure and Central Vascular Stiffness in Obese Children. Relationship to Metabolic Disturbances and Subclinical Cardiovascular Damage. Effect of Weight ReductionRecruitingNo Results AvailableCentral Blood Pressure|Obesity|Subclinical Organ Damage|Children|AdolescentBehavioral: Lifestyle interventionhttps://ClinicalTrials.gov/show/NCT01310088
9593495934Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander ReconstructionRecruitingNo Results AvailableBreast CancerDevice: Alloderm|Device: Surgimendhttps://ClinicalTrials.gov/show/NCT01310075
9593595935The Development of Diagnostic Biomarker Panels for Hepatitis and Liver CancerRecruitingNo Results AvailableHepatitis B,Chronic|Carcinoma,Hepatocellularhttps://ClinicalTrials.gov/show/NCT01310062
9593695936LEO 32731 - A Study in Healthy Male SubjectsCompletedNo Results AvailableHealthy SubjectsDrug: LEO 32731https://ClinicalTrials.gov/show/NCT01310049
9593795937A Study of Tarceva (Erlotinib) as First Line Therapy in Patients With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) MutationsActive, not recruitingNo Results AvailableNon-Squamous Non-Small Cell Lung CancerDrug: erlotinib [Tarceva]https://ClinicalTrials.gov/show/NCT01310036
9593895938Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected WomenRecruitingNo Results AvailableAntiretroviral Toxicityhttps://ClinicalTrials.gov/show/NCT01310023
9593995939Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic LeukemiaActive, not recruitingNo Results AvailableLeukemia, Lymphoblastic, Acute, Philadelphia-PositiveDrug: dasatinibhttps://ClinicalTrials.gov/show/NCT01310010
9594095940Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host DiseaseActive, not recruitingNo Results AvailableGraft Versus Host Disease|Systemic SclerodermaDrug: imatinib mesylate|Biological: rituximab|Other: laboratory biomarker analysis|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT01309997

* Görseller ve İçerik tekif hakkına sahip olabilir